Ex Parte Tuccori - Page 3



              Appeal No.  2003-0944                                                                 Page 3                
              Application No. 09/577,955                                                                                  
              1992).  The examiner acknowledges that Carr does not describe “combinations of                              
              isoleucine and lysine[ ] in a specific example” (Answer, page 4), but concludes that “it                    
              would have been obvious to one of ordinary skill in the art to use isoleucine or lysine or                  
              combinations thereof in a shampoo or conditioner because the reference teaches these                        
              amino acids to be preferred embodiments, included in a list of only nine amino acids”                       
              (id.).  Appellant, on the other hand, argues that “the present invention is [one] of                        
              selection,” and “it would not have been obvious to one of ordinary skill in the art to                      
              arrive at compositions having the recited amino acids merely because there is                               
              contained within [Carr] a list of only nine amino acids” (Brief, page 12).                                  
                     We cannot subscribe to appellant’s position.  Certainly it has been held that “[a]                   
              disclosure of millions of compounds does not render obvious a claim to three                                
              compounds, particularly when that disclosure indicates a preference leading away from                       
              the claimed compounds[,]” In re Baird, 16 F.3d 380, 382, 29 USPQ2d 1150, 1552 (Fed.                         
              Cir. 1994), but that is not the situation here.  The number of possible combinations of                     
              the nine amino acids preferred by Carr is not particularly large, nor is there anything in                  
              the reference to indicate a preference leading away from a combination of isoleucine                        
              and lysine.  The mere fact that Carr discloses a genus of hair treatment compositions                       
              (which undeniably embraces the hair treatment composition required by the claims)                           
              without particularly specifying the required composition, does not make any one of the                      
              compositions less obvious than any other, especially here, where the possibilities are                      
              relatively limited.  See Merck & Co. Inc. v. Biocraft Laboratories Inc., 874 F.2d 804, 807,                 
              10 USPQ2d 1843, 1846 (Fed. Cir. 1989), wherein it was held that disclosure of “a                            
              multitude of effective combinations” (approximately 1200) “does not render any                              
              particular combination less obvious . . . especially . . . [where] the claimed composition                  




Page:  Previous  1  2  3  4  5  6  Next 

Last modified: November 3, 2007